POLE and endometrial cancer: (28) classified 58 endometrial cancer or endometrial intraepithelial neoplasia (EIN) into four groups as per the ProMisE: 44 patients (75.9%) were classified as p53wt, 6 (10.3%) as MMRd, 4 (6.9%) as p53abn, and 4 (6.9%) as POLE-mutated.